Treatment Approaches for Patients With Oligodendrogliomas and Grade 2 Gliomas

Panelists discuss how they tailor treatment strategies for oligodendrogliomas and Grade 2 gliomas based on key clinical and molecular markers, with particular attention to insights from the CODEL trial and RTOG 9802 study.

EP: 1.Real-World Clinical Practice: Challenges With Glioma Management

Now Viewing

EP: 2.Treatment Approaches for Patients With Oligodendrogliomas and Grade 2 Gliomas

EP: 3.CATNON Trial: Concurrent Versus Adjuvant Temozolomide in Treating WHO Grade 3 Astrocytomas Without 1p/19q Codeletion

• How do you approach treatment decisions for patients with oligodendrogliomas and Grade 2 gliomas? What clinical and molecular factors most significantly influence your approach?
• CODEL TRIAL
• RTOG 9802

Recent Videos